Neochem Bio Solutions IPO Details

Bookbuilding IPO | ₹45 Cr | Listed at NSE SME | Tue, Dec 2, 2025 - Thu, Dec 4, 2025

Neochem Bio IPO Logo

Neochem Bio IPO is a book build issue of ₹44.97 crores. The issue is entirely a fresh issue of 0.46 crore shares of ₹44.97 crore.

Neochem Bio IPO bidding started from Dec 2, 2025 and ended on Dec 4, 2025. The allotment for Neochem Bio IPO was finalized on Dec 5, 2025. The shares got listed on NSE SME on Dec 9, 2025.

Neochem Bio IPO price band is set at ₹98 per share. The lot size for an application is 1,200. The minimum amount of investment required by an individual investor (retail) is ₹2,35,200 (2,400 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,600 shares), amounting to ₹3,52,800.

Vivro Financial Services Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Rikhav Securities Ltd..

Refer to Neochem Bio IPO RHP for detailed Information.

IPO Open

Tue, Dec 2, 2025

IPO Close

Thu, Dec 4, 2025

Issue Price

₹98 per share

Market Cap (Pre-IPO)

₹167.78 Cr

IPO Details

IPO Date2 to 4 Dec, 2025
Listed onTue, Dec 9, 2025
Face Value10 per share
Price Band₹93 to ₹98
Issue Price₹98 per share
Lot Size1,200 Shares
Sale TypeFresh capital only
Issue TypeBookbuilding IPO
Listing AtNSE SME

Total Issue Size45,88,800 shares
(agg. up to ₹45 Cr)
Reserved for Market Maker
2,32,800 shares
(agg. up to ₹2 Cr)
Rikhav Securities Ltd.
Fresh Issue
(Ex Market Maker)
43,56,000 shares
(agg. up to ₹43 Cr)
Net Offered to Public43,56,000 shares
(agg. up to ₹43 Cr)
Share Holding Pre Issue1,25,31,953 shares
Share Holding Post Issue1,71,20,753 shares
NSE Symbol NEOCHEM
ISININE21UM01018

IPO Timetable

Issue Reservation

Neochem Bio IPO comprises a total issue size of 45,88,800 shares. The net offer to the public is 43,56,000 shares, after excluding 2,32,800 shares allotted on a firm basis. Of the Net offer 21,74,400 (49.92%) are allocated to QIB, 6,55,200 (15.04%) allocated to NII 15,26,400 (35.04%) allocated to RII.

Investor Category Shares Offered % of Net Issue% of Total Issue
QIB Shares Offered 21,74,40049.92%47.38%
  − Anchor Investor Shares Offered 13,03,20028.40%
  − QIB (Ex. Anchor) Shares Offered 8,71,20018.99%
NII (HNI) Shares Offered 6,55,20015.04%14.28%
  − bNII > ₹10L 4,36,8009.52%
  − sNII < ₹10L 2,18,4004.76%
Retail Shares Offered 15,26,40035.04%33.26%
Firm Reservations
Market Maker Shares Offered 2,32,8005.07%
Total Shares Offered 45,88,800100.00%100.00%

IPO Lot Size

Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof. 

Application Lots Shares Amount
Individual investors (Retail) (Min) 2 2,400 ₹2,35,200
Individual investors (Retail) (Max) 2 2,400 ₹2,35,200
S-HNI (Min) 3 3,600 ₹3,52,800
S-HNI (Max) 8 9,600 ₹9,40,800
B-HNI (Min) 9 10,800 ₹10,58,400
IPO Subscription Details

IPO Anchor Investors

Neochem Bio IPO raises ₹12.77 crore from anchor investors. Neochem Bio IPO Anchor bid date is December 1, 2025.
📝 Anchor Investors Letter (PDF)

Bid DateMon, Dec 1, 2025
Shares Offered13,03,200
Anchor Portion (₹ Cr.)12.77
Anchor lock-in period end date for 50% shares (30 Days)Sun, Jan 4, 2026
Anchor lock-in period end date for remaining shares (90 Days)Thu, Mar 5, 2026

About Neochem Bio Solutions Ltd.

Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.

The company products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.

The company offer a comprehensive range of textile and garment washing auxiliaries such as pre-treatment, dyeing, finishing, printing and coating applications across all fabric and garment substrates compatible with various processing machines.

The company has its manufacturing facility located at Saket Industrial Estate, Village Moraiya, Ta. Sanand, Dist-Ahmedabad, which has an installed capacity of 22,000 metric ton per annum (“MTPA”) with a total area of 6,763 square meters.

Competitve Strengths:

  • Strengthening the presence across end-user application industries
  • Commitment to continuous development of innovative performance chemistries and sustainable solutions
  • Continued focus on expansion of geographical presence
  • Leverage existing strategic collaborations and partnerships to diversify end user industries

Company Financials (Restated)

Neochem Bio Solutions Ltd.'s revenue increased by 39% and profit after tax (PAT) rose by 330% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets96.4978.8964.0650.60
Total Income47.1886.1562.0148.79
Profit After Tax5.487.751.801.07
EBITDA8.5913.115.994.23
NET Worth32.2419.7512.008.05
Reserves and Surplus19.7013.085.332.63
Total Borrowing38.5435.6233.3226.24
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 Funding the long-term working capital requirements of the Company 23.90
2 Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company 10.00
3 General Corporate Purposes 6.44

Key Performance Indicator (KPI)

Pre IPOPost IPO
EPS (₹)6.186.41
P/E (x)15.8515.3
Promoter Holding91.12%66.7%
Market Cap167.78 Cr.
Swapnil Rameshbhai Makati and Hemangini Swapnil Dathia are the promoters of the company.
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2025 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2025 available in RHP.

IPO Review

[Dilip Davda]
NBSL is engaged in the manufacturing and marketing of specialty performance chemicals with a diverse portfolio of 350+ customized formulations. The company marked growth in its top and bottom lines. The surge in bottom line was due to value added high margin products. It is poised for bright prospects ahead with vide range of products offering. It has wide list of end users with long term  relationship, that augurs well.. Based on its recent financial data, the issue appears fully priced. Investors may park funds for medium to long term.
Read detail review...

Neochem Bio IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers1200
Members0000

Neochem Bio IPO Subscription Status (Bidding Detail)

The Neochem Bio IPO is subscribed 15.52 times on December 4, 2025 6:19:59 PM (Day 3). The public issue subscribed 9.42 times in the individual investors category, 21.97 times in the QIB category, and 21.15 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category Subscription (times) Shares Offered Shares bid for Total Application
QIB (Ex Anchor)21.978,71,2001,91,42,40027
NII* 21.156,55,2001,38,55,2001,629
    bNII (bids above ₹10L)25.784,36,8001,12,60,800
    sNII (bids below ₹10L)11.882,18,40025,94,400
Individual Investor9.4215,26,4001,43,76,0005,990
Total15.5230,52,8004,73,73,6007,646

Total Application : 7,646

*Market Maker portion is not included to NII/HNI.

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Fees payable to BRLM and commission (including selling commission, brokerage and underwriting commission) 3.22
2 Commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Issue and bidding/uploading charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs 0.01
3 Fees payable to the Registrar to the Issue 0.01
4 Listing fees, SEBI filing fees, NSE processing fees and other regulatory expenses 0.06
5 Printing and stationery expenses 0.02
6 Advertising and marketing expenses 0.29
7 Fees payable to legal counsel 0.12
8 Miscellaneous (including brokerage and selling commission and bidding charges of members of the syndicate, marketing and selling expenses, fees payable to auditors, market maker, consultants, market research firms and other professional agencies, stamp duty charges and other miscellaneous expenses) 0.92

Listing Day Trading Information

Price DetailsNSE SME
Final Issue Price98.00
Open108.00
Low102.60
High113.40
Last Trade111.80

Check IPO Performance…

IPO Registrar

MUFG Intime India Pvt.Ltd.

Contact Details

Neochem Bio Solutions Ltd. Address
303,
W1, Opp. Vikramnagar Colony,
Off. Iscon- Ambli Road,
Ahmedabad, Gujarat, 380058
Open an Instant Account with Zerodha

IPO FAQs

Neochem Bio IPO is a SME IPO of 45,88,800 equity shares of the face value of ₹10 aggregating up to ₹45 Crores. The issue is priced at ₹98 per share. The minimum order quantity is 1200.

The IPO opens on Tue, Dec 2, 2025, and closes on Thu, Dec 4, 2025.

MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Zerodha customers can apply online in Neochem Bio IPO using UPI as a payment gateway. Zerodha customers can apply in Neochem Bio IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Neochem Bio IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Neochem Bio IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Neochem Bio IPO opens on Tue, Dec 2, 2025 and closes on Thu, Dec 4, 2025.

Neochem Bio IPO lot size is 1200, and the minimum amount required for application is ₹2,35,200, with 2 lots being the minimum application size.

You can apply in Neochem Bio IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Neochem Bio IPO will be done on Friday, December 5, 2025, and the allotted shares will be credited to your demat account by Mon, Dec 8, 2025. Check the Neochem Bio IPO allotment status.

The Neochem Bio IPO listing date is on Tue, Dec 9, 2025.

Compare: